Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic cardiomyopathy (HCM), at the American ...

Years of studying Satoshi Nakamoto led me to a new prime suspect. What if crypto’s creator isn’t the benign figure people ...